Servicio de Microbiología Clínica, Hospital Universitario 12 de Octubre, Avenida de Córdoba sn, Madrid 28041, Spain.
Nephrol Dial Transplant. 2011 Mar;26(3):948-55. doi: 10.1093/ndt/gfq481. Epub 2010 Aug 11.
Approximately 25% of haemodialysis (HD) patients use catheters as vascular access. Catheter-related bloodstream infections (CRBSI) are a major risk in this population. The objective of our study was to determine whether endoluminal catheter colonization (ECC) predicts CRBSI.
We followed up a cohort of HD patients in our institution who underwent HD with tunnelled cuffed central venous catheters (TCC) between December 2006 and June 2008. Colonization of the inner catheter lumen was assessed every 15 days immediately before HD by culture of blood-heparin mixture and the time to positivity (TTP) was recorded by the BacT/Alert automated system. CRBSI was confirmed by differential TTP (> 2 h) between TCC and peripheral blood cultures.
We studied 51 patients who required 64 TCC. The incidence of CRBSI was 1.65 episodes per 1000 catheter-days, with Staphylococcus epidermidis being the most common cause of infection (76.2%). ECC was more frequent in the CRSBI group than in the non-CRBSI group (100 vs 5.4%, P < 0.001). For S. epidermidis CRBSIs, the median time from ECC to CRBSI was 31.5 days (interquartile range, 27.0-79.0). The sensitivity, specificity and negative and positive predictive values of arterial lumen cultures for S. epidermidis CRBSIs were 100, 96.3, 92.3 and 100%, respectively, while for venous culture, these values were 92.3, 96.3, 92.3 and 96.3%, respectively. For predicting S. epidermidis CRBSI, endoluminal cultures with a TTP of ≤ 14 h had sensitivity and specificity of 52.1 and 97.7%, respectively.
This study shows that ECC may predict the risk of developing CRSBI. Surveillance cultures could, therefore, be used to triage individual HD patients who might benefit from specific intervention measures.
约 25%的血液透析(HD)患者使用导管作为血管通路。导管相关血流感染(CRBSI)是该人群的主要风险。我们研究的目的是确定管腔内导管定植(ECC)是否可预测 CRBSI。
我们对 2006 年 12 月至 2008 年 6 月期间在我院接受经皮隧道带套中央静脉导管(TCC)HD 的患者进行了队列研究。在每次 HD 前 15 天,通过培养血肝素混合物评估内导管腔的定植情况,并通过 BacT/Alert 自动系统记录阳性时间(TTP)。通过 TCC 和外周血培养之间的差异 TTP(>2 小时)来确认 CRBSI。
我们研究了 51 名需要 64 个 TCC 的患者。CRBSI 的发生率为每 1000 个导管日 1.65 例,感染的最常见原因是表皮葡萄球菌(76.2%)。CRBSI 组的 ECC 发生率高于非 CRBSI 组(100%比 5.4%,P<0.001)。对于表皮葡萄球菌 CRBSI,从 ECC 到 CRBSI 的中位时间为 31.5 天(四分位间距,27.0-79.0)。动脉腔培养对表皮葡萄球菌 CRBSI 的敏感性、特异性、阴性和阳性预测值分别为 100%、96.3%、92.3%和 100%,而静脉培养的相应值分别为 92.3%、96.3%、92.3%和 96.3%。对于预测表皮葡萄球菌 CRBSI,TTP≤14 小时的管腔培养的敏感性和特异性分别为 52.1%和 97.7%。
本研究表明,ECC 可能预测发生 CRBSI 的风险。因此,监测培养物可用于对可能受益于特定干预措施的个别 HD 患者进行分诊。